These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31156624)

  • 1. Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.
    Idborg H; Zandian A; Ossipova E; Wigren E; Preger C; Mobarrez F; Checa A; Sohrabian A; Pucholt P; Sandling JK; Fernandes-Cerqueira C; Rönnelid J; Oke V; Grosso G; Kvarnström M; Larsson A; Wheelock CE; Syvänen AC; Rönnblom L; Kultima K; Persson H; Gräslund S; Gunnarsson I; Nilsson P; Svenungsson E; Jakobsson PJ
    Front Immunol; 2019; 10():1029. PubMed ID: 31156624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS
    Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
    Šumová B; Cerezo LA; Szczuková L; Nekvindová L; Uher M; Hulejová H; Moravcová R; Grigorian M; Pavelka K; Vencovský J; Šenolt L; Závada J
    Rheumatol Int; 2019 Mar; 39(3):469-478. PubMed ID: 30392117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
    Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
    Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
    Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
    Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.
    Cham CM; Ko K; Niewold TB
    Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
    Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of IRF5 hyperactivation protects from lupus onset and severity.
    Song S; De S; Nelson V; Chopra S; LaPan M; Kampta K; Sun S; He M; Thompson CD; Li D; Shih T; Tan N; Al-Abed Y; Capitle E; Aranow C; Mackay M; Clapp WL; Barnes BJ
    J Clin Invest; 2020 Dec; 130(12):6700-6717. PubMed ID: 32897883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4.
    Wang C; Sandling JK; Hagberg N; Berggren O; Sigurdsson S; Karlberg O; Rönnblom L; Eloranta ML; Syvänen AC
    Ann Rheum Dis; 2013 Jan; 72(1):96-103. PubMed ID: 22730365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
    Ban T; Sato GR; Tamura T
    Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF5 Variants Are Risk Factors for Systemic Lupus Erythematosus in Two Mexican Populations.
    López-Briceño IA; Ramírez-Bello J; Montúfar-Robles I; Barbosa-Cobos RE; Ángulo-Ramírez AV; Valencia-Pacheco G
    J Clin Rheumatol; 2024 Oct; 30(7):283-290. PubMed ID: 39271190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus.
    Hou G; Zhou T; Xu N; Yin Z; Zhu X; Zhang Y; Cui Y; Ma J; Tang Y; Cheng Z; Shen Y; Chen Y; Zou LH; Wang YF; Yin Z; Guo Y; Ding H; Ye Z; Shen N
    Arthritis Rheumatol; 2023 Apr; 75(4):574-585. PubMed ID: 36245280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
    Brune Z; Rice MR; Barnes BJ
    Front Immunol; 2020; 11():1143. PubMed ID: 32582209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-Specific Functionality of an Interferon Regulatory Factor 5 Lupus Risk Haplotype: Lack of B Cell Intrinsic Effects.
    Calise J; Marquez Renteria S; Gregersen PK; Diamond B
    Front Immunol; 2018; 9():996. PubMed ID: 29867973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.